Immucor, Inc.-医療機器分野:企業M&A・提携分析

◆英語タイトル:Immucor, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011021
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its major customers include hospitals, clinical laboratories and blood banks. Immucor offers its solutions to blood banks, transfusion laboratories and small- and medium-sized hospitals. The company has operations in Germany, Italy, Portugal, Canada, Spain, Belgium, France, India, Japan, the UK and the US; and it has manufacturing facilities in US and Canada. Immucor is headquartered in Norcross, Georgia, the US.

Immucor, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immucor, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immucor, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immucor, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immucor, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Immucor, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immucor, Inc., Medical Equipment, Deal Details 10
Asset Purchase 10
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 10
Private Equity 12
TPG Capital Completes Acquisition Of Immucor For US$1.94 Billion 12
Partnerships 14
Immucor Enters into Co-Marketing Agreement with Sirona Genomics 14
BioCSL Enters into Distribution Agreement with Immucor for Capture 15
Acquisition 16
Immucor Acquires Sentilus 16
Immucor Acquires Organ-i, Molecular Diagnostic Company 17
Immucor, Inc. – Key Competitors 18
Immucor, Inc. – Key Employees 19
Immucor, Inc. – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Product News 23
Feb 17, 2017: Immucor Announces the Launch of Pak Lx RUO in the United States 23
03/21/2016: Immucor’s ImmuLINK Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType HEA 24
02/03/2016: Immucor and Sirona Genomics Announce CE Mark for MIA FORA NGS HLA Typing Solution 25
Product Approvals 26
Mar 21, 2016: Immucor’s ImmuLINK Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType HEA 26
Feb 03, 2016: Immucor and Sirona Genomics Announce CE Mark for MIA FORA NGS HLA Typing Solution 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Immucor, Inc., Medical Equipment, Key Facts 2
Immucor, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Immucor, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Immucor, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Immucor, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Immucor, Inc., Deals By Market, 2011 to YTD 2017 8
Immucor, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 10
TPG Capital Completes Acquisition Of Immucor For US$1.94 Billion 12
Immucor Enters into Co-Marketing Agreement with Sirona Genomics 14
BioCSL Enters into Distribution Agreement with Immucor for Capture 15
Immucor Acquires Sentilus 16
Immucor Acquires Organ-i, Molecular Diagnostic Company 17
Immucor, Inc., Key Competitors 18
Immucor, Inc., Key Employees 19
Immucor, Inc., Other Locations 20
Immucor, Inc., Subsidiaries 21

★海外企業調査レポート[Immucor, Inc.-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KornFerry International (KFY):企業の財務・戦略的SWOT分析
    KornFerry International (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • General Mills Inc:企業の戦略・SWOT・財務情報
    General Mills Inc - Strategy, SWOT and Corporate Finance Report Summary General Mills Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Co-Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Blueprint Medicines Corp (BPMC):企業の財務・戦略的SWOT分析
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, discovers and develops precision therapies for the treatment of cancers and rare diseases. The company offers AYVAKIT (avapritinib) medicine to treat gastrointestinal stromal tumor (GIST); and GAVRETO (pralse …
  • Sphere Fluidics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Sphere Fluidics Ltd (Sphere Fluidics) is a life sciences company that offers analytical instrumentation and collaborative research services. The company offers products such as research instruments, consumables and industrial systems. Its research instruments include picodroplet single cell …
  • NantKwest Inc (NK):企業の財務・戦略的SWOT分析
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Land Securities Group Plc:企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Valvoline Inc (VVV):企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析
    Summary Matrix Composites & Engineering Ltd (Matrix) is a manufacturer and supplier of engineered products and services. The company manufactures and distributes engineered products for developing and utilizing advanced composite and polymer materials technologies. Its products include well construc …
  • British Columbia Ferry Services Inc.:企業の戦略的SWOT分析
    British Columbia Ferry Services Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Aselsan Elektronik Sanayi Ve Ticaret A.S.:企業の戦略・SWOT・財務分析
    Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary Aselsan Elektronik Sanayi Ve Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Yamaha Corporation:企業の戦略・SWOT・財務情報
    Yamaha Corporation - Strategy, SWOT and Corporate Finance Report Summary Yamaha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Erasmus MC-医療機器分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. Suburban Propane also provides installation and service of various types …
  • Aibel AS:企業の戦略的SWOT分析
    Aibel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Landsvirkjun hf:電力:M&Aディール及び事業提携情報
    Summary Landsvirkjun hf (Landsvirkjun) is a state-owned energy utility that conducts the generation and transmission of electricity in Iceland. It generates electricity through several renewable sources such as hydro, geothermal, and wind. Through subsidiaries, the company also offers telecommunicat …
  • Modec Inc (6269):企業の財務・戦略的SWOT分析
    Modec Inc (6269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Addex Therapeutics Ltd (ADXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Addex Therapeutics Ltd (Addex) develops orally available, small molecule allosteric modulators for neurological disorders. The company’s product pipeline consists of its lead products, dipraglurant (mGluR5 negative allosteric modulator or NAM) to treat Parkinson’s disease levodopa-induced dy …
  • Weatherford International plc:企業の戦略・SWOT・財務情報
    Weatherford International plc - Strategy, SWOT and Corporate Finance Report Summary Weatherford International plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆